Saturday, October 1, 2022


Biotechnology News Magazine

Biotium Announces Acquisition of CAT5™ FFPE RNA/DNA Extraction Technology from Cell Data Sciences

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Biotium, a supplier of cutting-edge life science reagents, is announcing the acquisition of Cell Data Sciences RNAstorm™ and DNAstorm™ kits for RNA/DNA extraction. Biotium, which previously distributed the Cell Data Sciences kits, will now be their sole manufacturer. The extraction kits will be offered from the Biotium website and authorized distributors.

Cell Data Sciences developed RNAstorm™ and DNAstorm™ FFPE extraction kits based on research initiated at Stanford University. The kits feature a novel CAT5™ catalytic technology for enzymatic reversal of formaldehyde crosslinking in FFPE tissue samples. This revolutionary technology offers higher yields of amplifiable nucleic acids from formalin-fixed samples compared to leading competitors’ kits. The increased yields of higher quality RNA/DNA allow for more robust results in downstream applications such as next-gen sequencing (NGS), RT-PCR, and microarrays.

All RNAstorm™ and DNAstorm™ kits will continue to use the Cell Data Sciences catalog numbers with revised product names. Biotium will also continue to offer the RNAstorm™ RNA extraction kit for fresh cells and tissues. This simple spin column-based RNA extraction kit offers higher yields than leading competitor kits (up to 120 ug RNA) from fresh cells and tissues in as little as 20 minutes. For customers who wish to extract DNA and RNA from the same FFPE sample, Biotium will offer a combination of both the DNAstorm™ and RNAstorm™ FFPE extraction kits at a discounted price when compared to purchasing each kit separately. See the catalog numbers, revised product names, and links to all product pages below:

CELLDATA RNAstorm™ FFPE RNA Extraction Kit (Catalog No. CD501)

CELLDATA DNAstorm™ FFPE DNA Extraction Kit (Catalog No. CD502)

DNAstorm™/RNAstorm™ Combination Kit for FFPE Tissues (Catalog No. CD503)

CELLDATA RNAstorm™ Fresh Cell and Tissue RNA Isolation Kit (Catalog No. CD504)

With this acquisition, Biotium grows its portfolio of technologies and products for molecular biology research. For RNA workflows, see our RNA research solutions page to learn more about Biotium’s products for RNA gel staining, RNA quantitation on Qubit® or microplate reader, and RNase decontamination. Also see our technologies for DNA quantitation and qPCR .

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine